One Stop Shop for All Your Market Research Reports

Global Rotavirus Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15?34% of severe diarrhea in the developing world and 37?96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized. The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age. The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus. The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries. Scope of the Report: This report focuses on the Rotavirus Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for Rotavirus Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. Market Segment by Manufacturers, this report covers Bharat Biotech Merck & Co., Inc GlaxoSmithKline plc Lanzhou Institute of Biological Bharat Biotech International Limited Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Rotarix RotaTeq Rotavac Rotavin-M1 Lanzhou lamb Others Market Segment by Applications, can be divided into Adult Pediatric There are 15 Chapters to deeply display the global Rotavirus Vaccines market. Chapter 1, to describe Rotavirus Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Rotavirus Vaccines, with sales, revenue, and price of Rotavirus Vaccines, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Rotavirus Vaccines, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018; Chapter 12, Rotavirus Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023; Chapter 13, 14 and 15, to describe Rotavirus Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents 1 Market Overview 1.1 Rotavirus Vaccines Introduction 1.2 Market Analysis by Type 1.2.1 Rotarix 1.2.2 RotaTeq 1.2.3 Rotavac 1.2.4 Rotavin-M1 1.2.5 Lanzhou lamb 1.2.6 Others 1.3 Market Analysis by Applications 1.3.1 Adult 1.3.2 Pediatric 1.4 Market Analysis by Regions 1.4.1 Nort
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3480
Multi User US $5220
Corporate User US $6960
About this Report
Report ID 307004
Category
  • Pharmaceuticals and Healthcare
Published on 31-Aug
Number of Pages 130
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(45)